TapewireFind a company

person · Reporting owner

Juvenal Tobin W

Disclosed activity across 1 company

Tapewire entity
360
SEC CIK
0001856542

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
CASTLE BIOSCIENCES INCCSTL · Entity 359Chief Commercial OfficerOctober 12, 2026October 14, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

CASTLE BIOSCIENCES INC

Report date October 12, 2026 · Filed October 14, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect48,719 Reported balance After 2026-10-12 transaction · row 1
1 source row

Row 1 · 2026-10-12 · Sale · Disposed 3,288 · Balance 48,719

F1: This transaction was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 28, 2026.

F2: This transaction was executed in multiple trades at prices ranging from $33.52 to $34.03, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Filing footnotes · ownership attribution and instrument terms

F1: This transaction was made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 28, 2026.

F2: This transaction was executed in multiple trades at prices ranging from $33.52 to $34.03, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
December 10, 2024 Filed Dec 11, 2024 21:55 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionRestricted Stock Units · Derivative 6,169 $0.00 $0.00
Disclosure

SEC source: 0001447362-24-000200 · wk-form4_1733954143.xml · derivative · entry 10

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,170

Underlying: Common Stock · 6,169 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F5 · derivative.exercise_date: On December 10, 2021, the Reporting Person was granted 24,679 RSUs which vest in four equal installments beginning on December 10, 2022.

F5 · derivative.expiration_date: On December 10, 2021, the Reporting Person was granted 24,679 RSUs which vest in four equal installments beginning on December 10, 2022.

Read SEC document
December 10, 2024 Filed Dec 11, 2024 21:55 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionRestricted Stock Units · Derivative 1,750 $0.00 $0.00
Disclosure

SEC source: 0001447362-24-000200 · wk-form4_1733954143.xml · derivative · entry 9

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: On December 10, 2020, the Reporting Person was granted 7,000 RSUs which vest in four equal installments beginning on December 10, 2021.

F4 · derivative.expiration_date: On December 10, 2020, the Reporting Person was granted 7,000 RSUs which vest in four equal installments beginning on December 10, 2021.

Read SEC document
December 10, 2024 Filed Dec 11, 2024 21:55 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Tax withholdingCommon Stock 1,503 $29.63 $44,533.89
Disclosure

SEC source: 0001447362-24-000200 · wk-form4_1733954143.xml · nonDerivative · entry 6

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,173

Read SEC document
December 10, 2024 Filed Dec 11, 2024 21:55 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 6,169 Not disclosed Not disclosed
Disclosure

SEC source: 0001447362-24-000200 · wk-form4_1733954143.xml · nonDerivative · entry 5

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,676

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

Read SEC document
December 10, 2024 Filed Dec 11, 2024 21:55 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Tax withholdingCommon Stock 495 $29.63 $14,666.85
Disclosure

SEC source: 0001447362-24-000200 · wk-form4_1733954143.xml · nonDerivative · entry 4

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,507

Read SEC document
December 10, 2024 Filed Dec 11, 2024 21:55 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 1,750 Not disclosed Not disclosed
Disclosure

SEC source: 0001447362-24-000200 · wk-form4_1733954143.xml · nonDerivative · entry 3

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,002

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

Read SEC document
December 09, 2024 Filed Dec 11, 2024 21:55 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionRestricted Stock Units · Derivative 15,961 $0.00 $0.00
Disclosure

SEC source: 0001447362-24-000200 · wk-form4_1733954143.xml · derivative · entry 8

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,922

Underlying: Common Stock · 15,961 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F3 · derivative.exercise_date: On December 9, 2022, the Reporting Person was granted 63,844 RSUs which vest in four equal installments beginning on December 9, 2023.

F3 · derivative.expiration_date: On December 9, 2022, the Reporting Person was granted 63,844 RSUs which vest in four equal installments beginning on December 9, 2023.

Read SEC document
December 09, 2024 Filed Dec 11, 2024 21:55 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Tax withholdingCommon Stock 3,887 $30.91 $120,147.17
Disclosure

SEC source: 0001447362-24-000200 · wk-form4_1733954143.xml · nonDerivative · entry 2

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,252

Read SEC document
December 09, 2024 Filed Dec 11, 2024 21:55 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 15,961 Not disclosed Not disclosed
Disclosure

SEC source: 0001447362-24-000200 · wk-form4_1733954143.xml · nonDerivative · entry 1

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,139

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

Read SEC document
November 05, 2024 Filed Nov 7, 2024 21:12 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionStock option (right to buy) · Derivative 3,507 $0.00 Strike: $3.38 $0.00
Disclosure

SEC source: 0001447362-24-000178 · wk-form4_1731013900.xml · derivative · entry 4

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,603

Underlying: Common Stock · 3,507 shares

Expires 2029-03-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option are fully vested.

Read SEC document
November 05, 2024 Filed Nov 7, 2024 21:12 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 3,507 $35.56 $124,708.92
Disclosure

SEC source: 0001447362-24-000178 · wk-form4_1731013900.xml · nonDerivative · entry 2

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,178

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 10,2024.

F2 · price: This transaction was executed in multiple trades at prices ranging from $35.45 to $35.83, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 05, 2024 Filed Nov 7, 2024 21:12 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 3,507 $3.38 $11,853.66
Disclosure

SEC source: 0001447362-24-000178 · wk-form4_1731013900.xml · nonDerivative · entry 1

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 57,685

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 01, 2024 Filed Nov 5, 2024 21:33 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionStock option (right to buy) · Derivative 1,100 $0.00 Strike: $3.38 $0.00
Disclosure

SEC source: 0001447362-24-000173 · wk-form4_1730842399.xml · derivative · entry 4

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,110

Underlying: Common Stock · 1,100 shares

Expires 2029-03-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option are fully vested.

Read SEC document
November 01, 2024 Filed Nov 5, 2024 21:33 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 SaleCommon Stock 3,100 $35.39 $109,709.00
Disclosure

SEC source: 0001447362-24-000173 · wk-form4_1730842399.xml · nonDerivative · entry 2

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 54,178

F1 · kind: These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 10,2024.

F2 · price: This transaction was executed in multiple trades at prices ranging from $35.38 to $35.42, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
November 01, 2024 Filed Nov 5, 2024 21:33 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 1,100 $3.38 $3,718.00
Disclosure

SEC source: 0001447362-24-000173 · wk-form4_1730842399.xml · nonDerivative · entry 1

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 57,278

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 09, 2024 Filed Aug 13, 2024 22:16 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 GrantPerformance-Based Stock Unit · Derivative 10,641 $0.00 $0.00
Disclosure

SEC source: 0001447362-24-000132 · wk-form4_1723587370.xml · derivative · entry 4

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,641

Underlying: Common Stock · 10,641 shares

Expires not disclosed

F4 · derivative.exercise_price: Each PSU represents the right to receive one share of the Issuer's Common Stock. These PSUs represent the remaining 50% of the 2022 PSUs which are all subject to time-based vesting and will vest in full on the one-year anniversary of the Initial Vesting Date.

F4 · derivative.exercise_date: Each PSU represents the right to receive one share of the Issuer's Common Stock. These PSUs represent the remaining 50% of the 2022 PSUs which are all subject to time-based vesting and will vest in full on the one-year anniversary of the Initial Vesting Date.

F4 · derivative.expiration_date: Each PSU represents the right to receive one share of the Issuer's Common Stock. These PSUs represent the remaining 50% of the 2022 PSUs which are all subject to time-based vesting and will vest in full on the one-year anniversary of the Initial Vesting Date.

Read SEC document
August 09, 2024 Filed Aug 13, 2024 22:16 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Tax withholdingCommon Stock 2,592 $26.83 $69,543.36
Disclosure

SEC source: 0001447362-24-000132 · wk-form4_1723587370.xml · nonDerivative · entry 2

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,178

Read SEC document
August 09, 2024 Filed Aug 13, 2024 22:16 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 GrantCommon Stock 10,641 $0.00 $0.00
Disclosure

SEC source: 0001447362-24-000132 · wk-form4_1723587370.xml · nonDerivative · entry 1

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,770

F1 · shares: Represents 50% of the Performance-Based Stock Units ("PSUs") granted on December 23, 2022 ("2022 PSUs") that vested based on the satisfaction of certain performance criteria as certified by the board of directors of the Issuer on August 9, 2024 (the "Initial Vesting Date").

F2 · balance_after: Includes 1,272 shares acquired on February 29, 2024, under the Issuer's employee stock purchase plan.

Read SEC document
March 04, 2024 Filed Mar 6, 2024 23:07 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 GrantRestricted Stock Units · Derivative 55,243 $0.00 $0.00
Disclosure

SEC source: 0001447362-24-000027 · wk-form4_1709766451.xml · derivative · entry 1

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,243

Underlying: Common Stock · 55,243 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The RSU's vest in four equal annual installments beginning on March 04, 2025.

F2 · derivative.expiration_date: The RSU's vest in four equal annual installments beginning on March 04, 2025.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 22:16 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionStock option (right to buy) · Derivative 3,400 $0.00 Strike: $3.38 $0.00
Disclosure

SEC source: 0001447362-24-000004 · wk-form4_1704406567.xml · derivative · entry 5

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,210

Underlying: Common Stock · 3,400 shares

Expires 2029-03-12

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The shares subject to the option are fully vested.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 22:16 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionStock option (right to buy) · Derivative 3,301 $0.00 Strike: $2.39 $0.00
Disclosure

SEC source: 0001447362-24-000004 · wk-form4_1704406567.xml · derivative · entry 4

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,301 shares

Expires 2028-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The shares subject to the option are fully vested.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 22:16 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 3,400 $3.38 $11,492.00
Disclosure

SEC source: 0001447362-24-000004 · wk-form4_1704406567.xml · nonDerivative · entry 2

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,857

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 22:16 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 3,301 $2.39 $7,889.39
Disclosure

SEC source: 0001447362-24-000004 · wk-form4_1704406567.xml · nonDerivative · entry 1

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,457

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 10, 2023 Filed Dec 13, 2023 00:28 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionRestricted Stock Units · Derivative 1,750 $0.00 $0.00
Disclosure

SEC source: 0001447362-23-000175 · wk-form4_1702427329.xml · derivative · entry 10

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,750

Underlying: Common Stock · 1,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F5 · derivative.exercise_date: On December 10, 2020, the Reporting Person was granted 7,000 RSUs, which vest in four equal annual installments beginning on December 10, 2021.

F5 · derivative.expiration_date: On December 10, 2020, the Reporting Person was granted 7,000 RSUs, which vest in four equal annual installments beginning on December 10, 2021.

Read SEC document
December 10, 2023 Filed Dec 13, 2023 00:28 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionRestricted Stock Units · Derivative 6,170 $0.00 $0.00
Disclosure

SEC source: 0001447362-23-000175 · wk-form4_1702427329.xml · derivative · entry 9

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,339

Underlying: Common Stock · 6,170 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: On December 10, 2021, the Reporting Person was granted 24,679 RSUs, which vest in four equal annual installments beginning on December 10, 2022.

F4 · derivative.expiration_date: On December 10, 2021, the Reporting Person was granted 24,679 RSUs, which vest in four equal annual installments beginning on December 10, 2022.

Read SEC document
December 10, 2023 Filed Dec 13, 2023 00:28 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Tax withholdingCommon Stock 427 $20.17 $8,612.59
Disclosure

SEC source: 0001447362-23-000175 · wk-form4_1702427329.xml · nonDerivative · entry 6

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,156

Read SEC document
December 10, 2023 Filed Dec 13, 2023 00:28 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 1,750 Not disclosed Not disclosed
Disclosure

SEC source: 0001447362-23-000175 · wk-form4_1702427329.xml · nonDerivative · entry 5

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,583

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

Read SEC document
December 10, 2023 Filed Dec 13, 2023 00:28 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Tax withholdingCommon Stock 1,503 $20.17 $30,315.51
Disclosure

SEC source: 0001447362-23-000175 · wk-form4_1702427329.xml · nonDerivative · entry 4

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,833

Read SEC document
December 10, 2023 Filed Dec 13, 2023 00:28 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 6,170 Not disclosed Not disclosed
Disclosure

SEC source: 0001447362-23-000175 · wk-form4_1702427329.xml · nonDerivative · entry 3

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,336

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

Read SEC document
December 09, 2023 Filed Dec 13, 2023 00:28 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionRestricted Stock Units · Derivative 15,961 $0.00 $0.00
Disclosure

SEC source: 0001447362-23-000175 · wk-form4_1702427329.xml · derivative · entry 8

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,883

Underlying: Common Stock · 15,961 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F3 · derivative.exercise_date: On December 9, 2022, the Reporting Person was granted 63,844 RSUs, which vest in four equal annual installments beginning on December 9, 2023.

F3 · derivative.expiration_date: On December 9, 2022, the Reporting Person was granted 63,844 RSUs, which vest in four equal annual installments beginning on December 9, 2023.

Read SEC document
December 09, 2023 Filed Dec 13, 2023 00:28 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Tax withholdingCommon Stock 3,887 $20.17 $78,400.79
Disclosure

SEC source: 0001447362-23-000175 · wk-form4_1702427329.xml · nonDerivative · entry 2

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,166

Read SEC document
December 09, 2023 Filed Dec 13, 2023 00:28 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 15,961 Not disclosed Not disclosed
Disclosure

SEC source: 0001447362-23-000175 · wk-form4_1702427329.xml · nonDerivative · entry 1

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,053

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 21:21 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionStock option (right to buy) · Derivative 6,173 $0.00 Strike: $2.39 $0.00
Disclosure

SEC source: 0001447362-23-000044 · wf-form4_167787846333811.xml · derivative · entry 3

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,301

Underlying: Common Stock · 6,173 shares

Expires 2028-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option are fully vested.

Read SEC document
March 01, 2023 Filed Mar 3, 2023 21:21 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 6,173 $2.39 $14,753.47
Disclosure

SEC source: 0001447362-23-000044 · wf-form4_167787846333811.xml · nonDerivative · entry 1

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,092

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 880 shares acquired on February 28, 2023, under the Issuer's employee stock purchase plan.

Read SEC document
December 10, 2022 Filed Dec 13, 2022 21:35 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionRestricted Stock Units · Derivative 6,170 $0.00 $0.00
Disclosure

SEC source: 0001447362-22-000190 · wf-form4_167096730634496.xml · derivative · entry 7

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,509

Underlying: Common Stock · 6,170 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: On December 10, 2021, the Reporting Person was granted 24,679 RSUs, which vest in four equal annual installments beginning on December 10, 2022.

F4 · derivative.expiration_date: On December 10, 2021, the Reporting Person was granted 24,679 RSUs, which vest in four equal annual installments beginning on December 10, 2022.

Read SEC document
December 10, 2022 Filed Dec 13, 2022 21:35 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionRestricted Stock Units · Derivative 1,750 $0.00 $0.00
Disclosure

SEC source: 0001447362-22-000190 · wf-form4_167096730634496.xml · derivative · entry 6

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,500

Underlying: Common Stock · 1,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F3 · derivative.exercise_date: On December 10, 2020, the Reporting Person was granted 7,000 RSUs, which vest in four equal annual installments beginning on December 10, 2021.

F3 · derivative.expiration_date: On December 10, 2020, the Reporting Person was granted 7,000 RSUs, which vest in four equal annual installments beginning on December 10, 2021.

Read SEC document
December 10, 2022 Filed Dec 13, 2022 21:35 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Tax withholdingCommon Stock 1,503 $22.32 $33,546.96
Disclosure

SEC source: 0001447362-22-000190 · wf-form4_167096730634496.xml · nonDerivative · entry 4

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,039

Read SEC document
December 10, 2022 Filed Dec 13, 2022 21:35 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 6,170 Not disclosed Not disclosed
Disclosure

SEC source: 0001447362-22-000190 · wf-form4_167096730634496.xml · nonDerivative · entry 3

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,542

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

Read SEC document
December 10, 2022 Filed Dec 13, 2022 21:35 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Tax withholdingCommon Stock 427 $22.32 $9,530.64
Disclosure

SEC source: 0001447362-22-000190 · wf-form4_167096730634496.xml · nonDerivative · entry 2

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,372

Read SEC document
December 10, 2022 Filed Dec 13, 2022 21:35 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 1,750 Not disclosed Not disclosed
Disclosure

SEC source: 0001447362-22-000190 · wf-form4_167096730634496.xml · nonDerivative · entry 1

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,799

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

Read SEC document
December 09, 2022 Filed Dec 13, 2022 21:35 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 GrantRestricted Stock Units · Derivative 63,844 $0.00 $0.00
Disclosure

SEC source: 0001447362-22-000190 · wf-form4_167096730634496.xml · derivative · entry 5

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,844

Underlying: Common Stock · 63,844 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F2 · derivative.exercise_date: The RSU's vest in four equal annual installments beginning on December 9, 2023.

F2 · derivative.expiration_date: The RSU's vest in four equal annual installments beginning on December 9, 2023.

Read SEC document
November 10, 2022 Filed Nov 14, 2022 23:04 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionStock option (right to buy) · Derivative 3,221 $0.00 Strike: $2.39 $0.00
Disclosure

SEC source: 0001447362-22-000178 · wf-form4_166846702766955.xml · derivative · entry 5

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,474

Underlying: Common Stock · 3,221 shares

Expires 2028-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 25% of the 24,610 shares originally subject to the option vested on May 10, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.

Read SEC document
November 10, 2022 Filed Nov 14, 2022 23:04 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionStock option (right to buy) · Derivative 479 $0.00 Strike: $2.36 $0.00
Disclosure

SEC source: 0001447362-22-000178 · wf-form4_166846702766955.xml · derivative · entry 4

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 479 shares

Expires 2027-07-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: 25% of the 11,484 shares originally subject to the option vested on July 21, 2018, and the remaining shares vest in 36 equal monthly installments thereafter.

Read SEC document
November 10, 2022 Filed Nov 14, 2022 23:04 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 3,221 $2.39 $7,698.19
Disclosure

SEC source: 0001447362-22-000178 · wf-form4_166846702766955.xml · nonDerivative · entry 2

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,049

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 10, 2022 Filed Nov 14, 2022 23:04 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionCommon Stock 479 $2.36 $1,130.44
Disclosure

SEC source: 0001447362-22-000178 · wf-form4_166846702766955.xml · nonDerivative · entry 1

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,828

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 26, 2022 Filed Apr 28, 2022 23:20 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 GrantCommon Stock 2,230 Not disclosed Not disclosed
Disclosure

SEC source: 0001447362-22-000066 · wf-form4_165118794332101.xml · nonDerivative · entry 1

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Tobin W and Susan M Juvenal Family Revocable Trust

Disclosed balance after: 2,230

F1 · shares: The reporting person acquired 2,230 shares of common stock on April 26, 2022, as consideration for the Reporting Person's equity securities of AltheaDx, Inc. ("AltheaDx"), which Castle Biosciences, Inc. ("Castle Biosciences") acquired by merger on April 26, 2022 (the "Merger") pursuant to an Agreement and Plan of Merger agreement dated April 4, 2022 (the "Merger Agreement"). Of the 2,230 shares issued to the Reporting Person in the Merger, 189 shares are currently being held in escrow and are subject to forfeiture for a specified period following the Merger to satisfy indemnification claims arising of Castle Biosciences, if any.

F2 · shares: The Merger Agreement provides that the former securityholders of AltheaDx may receive additional consideration, payable 50% in cash and 50% in shares of common stock of Castle Biosciences, based on the achievement of certain commercial milestones with related dates or performance periods through December 31, 2024 (the "Milestone Payments"). The portion of the Milestone Payments payable in shares of common stock will be valued at the volume-weighted average price for the 20 trading days ending as of the applicable determination date. The number of shares issuable is subject to certain limitations set forth in the Merger Agreement. The Reporting Person's right to receive additional shares pursuant to this earn-out right became fixed and irrevocable on April 26, 2022, the effective date of the merger.

F3 · price: The number of shares issuable was determined pursuant to a formula set forth in the Merger Agreement, which provided that, for the purpose of determining the number of shares issuable, the shares of Castle Biosciences common stock would be valued at $42.54, which represents the volume weighted average share price of the stock for the 20 trading days immediately preceding the date of the Merger Agreement.

F4 · ownership.nature: Held by Tobin W and Susan M Juvenal Family Revocable Trust of which the Reporting Person and his spouse are the trustees and the Reporting Person, his spouse and their children are the beneficiaries.

Read SEC document
December 10, 2021 Filed Dec 15, 2021 00:54 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Exercise / conversionRestricted Stock Units · Derivative 1,750 $0.00 $0.00
Disclosure

SEC source: 0001447362-21-000264 · wf-form4_163952966749548.xml · derivative · entry 5

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,250

Underlying: Common Stock · 1,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F5 · derivative.exercise_date: On December 10, 2020, the Reporting Person was granted 7,000 RSUs, which vest in four equal annual installments beginning on December 10, 2021.

F5 · derivative.expiration_date: On December 10, 2020, the Reporting Person was granted 7,000 RSUs, which vest in four equal annual installments beginning on December 10, 2021.

Read SEC document
December 10, 2021 Filed Dec 15, 2021 00:54 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 GrantRestricted Stock Units · Derivative 24,679 $0.00 $0.00
Disclosure

SEC source: 0001447362-21-000264 · wf-form4_163952966749548.xml · derivative · entry 4

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,679

Underlying: Common Stock · 24,679 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's Common Stock.

F4 · derivative.exercise_date: The RSUs vest in four equal annual installments beginning on December 10, 2022.

F4 · derivative.expiration_date: The RSUs vest in four equal annual installments beginning on December 10, 2022.

Read SEC document
December 10, 2021 Filed Dec 15, 2021 00:54 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 GrantStock option (right to buy) · Derivative 42,550 $0.00 Strike: $40.52 $0.00
Disclosure

SEC source: 0001447362-21-000264 · wf-form4_163952966749548.xml · derivative · entry 3

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,550

Underlying: Common Stock · 42,550 shares

Expires 2031-12-09

F3 · derivative.exercise_date: 25% of the shares shall vest on December 10, 2022, and the remaining shares shall vest in 36 equal monthly installments thereafter.

Read SEC document
December 10, 2021 Filed Dec 15, 2021 00:54 UTC CASTLE BIOSCIENCES INC CSTL · Entity 359 Tax withholdingCommon Stock 427 $40.52 $17,302.04
Disclosure

SEC source: 0001447362-21-000264 · wf-form4_163952966749548.xml · nonDerivative · entry 2

Juvenal Tobin W · CIK 0001856542 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,855

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.